The IP Market Report “IP in MedTech” provides IP experts with a strategic overview of the European medical technology👉 Application of technology to diagnose, treat, and improve health outcomes. IP landscape and its implications for IP practice, advisory work, and business development. It identifies the topics shaping the MedTech IP market, the institutions and practitioners driving the discussion, and the concrete advisory needs emerging across medical technology, digital health, AI-enabled healthcare, and connected medical devices. Rather than focusing on isolated legal developments or procedural patent👉 A legal right granting exclusive control over an invention for a limited time. issues, the report examines how IP experts can translate MedTech-specific IP challenges into relevant positioning, services, and client opportunities. It connects patentability questions, design protection, trade secrets, regulatory developments, software and AI protection strategies, data governance, cybersecurity requirements, investor expectations, and commercial realities into a practical market-intelligence snapshot. A key message is that MedTech companies increasingly require integrated IP support that goes beyond prosecution or litigation👉 The formal process of resolving disputes through proceedings in court worldwide. alone: they need guidance on combining patents, trade secrets and design rights, protecting AI and software-driven innovation👉 Practical application of new ideas to create value., navigating Article 53(c) EPC restrictions, aligning IP with MDR, AI Act, EHDS and Data Act obligations, structuring data and trade-secret governance, preparing investor-facing IP strategies, managing regulatory disclosure risks, and translating IP protection into defensible commercial control points across increasingly connected healthcare ecosystems.
Send download link to:IP Market Report: IP in MedTech
Table of Contents
1. Current Topics / News
Current developments in MedTech IP are presented as interconnected market shifts across patents, AI, software, trade secrets, design protection, and data regulation. The section shows how AI-enabled medical devices, connected healthcare, and digital health technologies are reshaping IP priorities, while regulatory developments such as EHDS, the EU Data Act, MDR/IVDR reform, the AI Act, CRA, and NIS2 increasingly influence protection strategies. Particular emphasis is placed on trade-secret governance for AI and data assets, evolving EPO practice around medical-method exclusions and AI patentability, expanded design protection for digital products, and the growing need to combine patents, trade secrets, regulatory strategy, and compliance considerations into integrated MedTech IP approaches.
2. Key Voices & Contributions
The European MedTech IP discussion is shaped by a concentrated group of patent attorneys, practitioners, and industry institutions driving visibility around emerging MedTech-specific IP topics. The section highlights contributors shaping the conversation around AI and software protection, trade secrets for training data, medical-method exclusions, second medical use, digital health patenting, funding readiness, and MedTech litigation strategy. Particular emphasis is placed on voices connecting doctrinal IP developments with practical commercial questions, alongside institutional actors such as MedTech Europe and BVMed, whose data, policy positions, and market analyses increasingly influence strategic decisions across the European MedTech ecosystem.
3. Topic Clusters
The European MedTech IP market is structured around recurring topic clusters that reveal where legal developments, regulatory activity, investor pressure, and advisory demand increasingly concentrate. The section identifies major focus areas ranging from classical patentability questions and AI-driven medical technologies to software as a medical device👉 Software intended for medical purposes that functions without a hardware device., trade secrets, connected healthcare, digital regulation, and commercial IP topics such as fundraising and M&A. Particular emphasis is placed on where market demand outpaces existing service maturity, highlighting emerging opportunities around AI, data governance, regulatory-IP interaction, and software-related MedTech advisory work.
4. Market Needs
MedTech companies increasingly require IP support that extends beyond individual protection rights toward integrated strategic decision-making. The section highlights demand for combining patents, trade secrets, designs, contracts, and regulatory considerations into coherent protection strategies aligned with commercial realities. Particular emphasis is placed on identifying defensible control points, managing dependencies across connected healthcare ecosystems, integrating AI and software protection with regulatory requirements, strengthening trade-secret governance, and translating IP expertise into business-relevant decision frameworks for innovation, investment, and growth.
5. Opportunity Map for IP Experts
Emerging MedTech advisory needs are translated into concrete service opportunities that IP experts can package, position, and bring to market. The section connects demand areas such as AI-enabled medical devices, trade-secret governance, EHDS readiness, regulatory-IP integration, fundraising preparation, and MedTech M&A due diligence with specific client groups and business-development approaches. Particular emphasis is placed on turning existing IP capabilities into visible, commercially understandable service propositions that align with how MedTech companies search for expertise and make strategic decisions.
6. What this means for Private Practice
Successful MedTech-focused IP practices increasingly require positioning that reflects the interdisciplinary reality of connected healthcare innovation. The section highlights the importance of treating MedTech as a multi-right practice that combines patents, trade secrets, designs, contracts, and regulatory considerations rather than handling IP disciplines in isolation. Particular emphasis is placed on publishing around integration questions rather than purely doctrinal topics, building visible market positioning around emerging advisory gaps, organising capabilities around commercial client problems, and communicating expertise in ways that align with how MedTech companies make strategic business decisions.
7. Outlook
The European MedTech IP landscape is expected to become increasingly shaped by AI, software-driven healthcare, connected devices, data regulation, and integrated protection strategies. The section highlights how developments around AI patentability, trade-secret governance, EHDS implementation, the EU Data Act, cybersecurity obligations, and evolving MedTech regulation are likely to create new advisory needs and reshape service models over the coming years. Particular emphasis is placed on the growing importance of commercially integrated IP strategies, MedTech-specific due diligence capabilities, and positioning that aligns IP expertise with the realities of connected healthcare ecosystems and business decision-making.
